BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15628904)

  • 41. Patients with epithelial cell abnormality in PAP smears: correlation of results with follow-up smears and cervical biopsies.
    Türkmen IÇ; Başsüllü N; Korkmaz P; Günenç B; Baykal CM; Güdücü N; Işçı H; Dünder I; Doğusoy GB
    Turk Patoloji Derg; 2013; 29(3):179-84. PubMed ID: 24022307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ThinPrep Pap Test. Accuracy for glandular disease.
    Ashfaq R; Gibbons D; Vela C; Saboorian MH; Iliya F
    Acta Cytol; 1999; 43(1):81-5. PubMed ID: 9987455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atypical squamous cells, cannot exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients.
    Patton AL; Duncan L; Bloom L; Phaneuf G; Zafar N
    Cancer; 2008 Dec; 114(6):481-8. PubMed ID: 18980288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of false-negative ThinPrep cervical smears in women with high-grade squamous intraepithelial lesions.
    Leung KM; Lam KK; Tse PY; Yeoh GP; Chan KW
    Hong Kong Med J; 2008 Aug; 14(4):292-5. PubMed ID: 18685162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative analysis of conventional Papanicolaou tests and a fluid-based thin-layer method.
    Limaye A; Connor AJ; Huang X; Luff R
    Arch Pathol Lab Med; 2003 Feb; 127(2):200-4. PubMed ID: 12562235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Practices of participants in the college of american pathologists interlaboratory comparison program in cervicovaginal cytology, 2006.
    Eversole GM; Moriarty AT; Schwartz MR; Clayton AC; Souers R; Fatheree LA; Chmara BA; Tench WD; Henry MR; Wilbur DC
    Arch Pathol Lab Med; 2010 Mar; 134(3):331-5. PubMed ID: 20196659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
    Nasser SM; Cibas ES; Crum CP; Faquin WC
    Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Only a small fraction of high-grade cervical lesions are discovered after an interpretation of atypical squamous cells of undetermined significance when using imager-assisted, liquid-based papanicolaou tests and the Bethesda 2001 system.
    Khan KA; Smith DA; Thrall MJ
    Arch Pathol Lab Med; 2013 Jul; 137(7):936-41. PubMed ID: 22994456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey.
    Abulafia O; Pezzullo JC; Sherer DM
    Gynecol Oncol; 2003 Jul; 90(1):137-44. PubMed ID: 12821354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Qualifying the cytologic diagnosis of "atypical squamous cells of undetermined significance" affects the predictive value of a squamous intraepithelial lesion on subsequent biopsy.
    Genest DR; Dean B; Lee KR; Sheets E; Crum CP; Cibas ES
    Arch Pathol Lab Med; 1998 Apr; 122(4):338-41. PubMed ID: 9648902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conventional cervical cytologic smears vs. ThinPrep smears. A paired comparison study on cervical cytology.
    Ferenczy A; Robitaille J; Franco E; Arseneau J; Richart RM; Wright TC
    Acta Cytol; 1996; 40(6):1136-42. PubMed ID: 8960019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
    Duby JM; DiFurio MJ
    Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunocytochemical detection of raf kinase inhibitor protein and human papillomavirus profiling of normal and abnormal cervical ThinPrep samples.
    Al-Awadhi R; Husain S; Chehadeh W; Al-Jassar W; Kapila K; Al-Mulla F
    Acta Cytol; 2013; 57(3):259-65. PubMed ID: 23636063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reprocessing unsatisfactory ThinPrep papanicolaou tests using a modified SurePath preparation technique.
    Randolph ML; Wu HH; Crabtree WN
    Cancer Cytopathol; 2014 May; 122(5):343-8. PubMed ID: 24940587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of CellSolutions BestPrep® automated thin-layer liquid-based cytology Papanicolaou slide preparation and BestCyte® cell sorter imaging system.
    Delga A; Goffin F; Kridelka F; Marée R; Lambert C; Delvenne P
    Acta Cytol; 2014; 58(5):469-77. PubMed ID: 25277345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-Grade Squamous Intraepithelial Lesion or High-Grade Squamous Intraepithelial Lesion? Concordance Between the Interpretation of Low-Grade Squamous Intraepithelial Lesion and High-Grade Squamous Intraepithelial Lesion in Papanicolaou Tests: Results From the College of American Pathologists PAP Education Program.
    Crothers BA; Ghofrani M; Zhao C; Dodd LG; Goodrich K; Husain M; Kurtycz DFI; Russell DK; Shen RZ; Souers RJ; Staats PN; Tabatabai ZL; Witt BL; Davey DD
    Arch Pathol Lab Med; 2019 Jan; 143(1):81-85. PubMed ID: 30133317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing cytology, colposcopy and human papillomavirus cervical intraepithelial lesion screening methods in women with systemic lupus erythematosus.
    García-Carrasco M; Mendoza-Pinto C; Méndez-Martínez S; Rodríguez-Reyes A; Munguía-Realpozo P; Taboada-Cole A; Vallejo-Ruiz V; Etchegaray-Morales I; Jiménez-Herrera R; Juárez-Melchor D; Villanueva-López I
    Lupus; 2020 Aug; 29(9):1060-1066. PubMed ID: 32501171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
    Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.